Medicinal potential of willow: A chemical perspective of aspirin discovery

Journal of Saudi Chemical Society

Volumn 14, Issue 3, 2010, Pages 317-322

  Mahdi, Jassem G ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aspirin; History; Philosophy; Salicin; Salicylic acid; Willow

Indexed keywords

EID: 84866310608     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2010.04.010     Document Type: Article

References (67)

1. Ackerknecht E.H. Therapeutics: From the Primitives to the 20th Century 1973, Hafner Press, NY.
2. Anderson F.J. An Illustrated History of the Herbals 1977, Columbia University Press, NY.
3. Barnes J., Anderson L.A., Phillipson J.D. Herbal Medicines: A Guide for Healthcare Professionals 2002, Pharmaceutical Press, London. second ed.
4. Baron J.A. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Progress in Experimental Tumor Research: COX-2, A New Target for Cancer Prevention and Treatment 2003, vol. 37:1-24. Karger, Basel, Freiburg.
5. Barrett B., Kiefer D., Rabago D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Alt. Ther. 1999, 5(4):40-48.
6. Bekemeier, H., 1977. In 100 Years of the Salicylic Acid as an Anti Rheumatic Grug. Martin-Luther University, Halle (Saale), Halle-Wittenberg, pp. 6-13.
7. Bradley P.R. British Herbal Compendium 1992, vol. 1. British Herbal Medicine Association, Bournemouth.
8. Chevallier A. The Encyclopedia of Medicinal Plants 1996, vol. 96. Dorling Kindersley, London, p. 128.
9. Chrubasik, S., Eisenberg, E., 2004. Willow Bark. <> (accessed 11.03.04). http://www.rzuser.uni-heidelberg.de/~cn6/iasp-sig-rp/willow.html.
10. Chrubasik, S., Shvartzman, P., 1999. Rheumatic pain treatment with willow bark (Salicis cortex). Coherence, 1. <> (accessed 11.03.04). http://www.iaam.nl/coherence/msaima/299-5.html.
11. Collier H.O. New light on how aspirin works. Nature 1969, 223(201):35-37.
12. Collier H.O. A pharmacological analysis of aspirin. Adv. Pharmacol. 1969, 7:333-405.
13. Cragg G.M., Newman D.J. Natural product drug discovery in the next millennium. Pharmaceut. Biol. 2001, 39:8-17.
14. Cunningham S. Cunningham's Encyclopedia of Magical Herbs 1996, Llewellyn Publications, St. Paul, Minnesota.
15. Dewick P.M. Medicinal Natural Products: A Biosynthetic Approach 2002, John Wiley and Sons, Ltd., Baffins Lane. second ed.
16. Durner J., Shah J., Klessig D.F. Salicylic acid and disease resistance in plants. Trends Plant Sci. 1997, 2:266-274.
17. Flieger, K., 2004. Aspirin: A New Look at an Old Drug. <> (accessed 15.03.04). http://www.fda.gov/opacom/catalog/aspirin.html.
18. Fluckinger F.A. Pharmazeutische Chemie 1888, R. Gaertner's Verlag, Berlin.
19. Funkhouser E.M., Sharp G.B. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995, 76(7):1116-1119.
20. Gerland H. New formation of salicylic acid. J. Chem. Soc. 1852, 5:133.
21. Gross M., Greenberg L.A. The Salicylates: A Critical Bibliographic Review 1948, Hill House Press, New Haven.
22. Hammond-Kosack K.E., Jones J.D.G. Resistance gene-dependent plant defence responses. Plant Cell 1996, 8:1773-1791.
23. Herschman H.R. Prostaglandin synthase-2. Biochem. Biophys. Acta 1996, 1299:125-140.
24. Higgs G.A., Vane J.R. Inhibition of cyclooxigenase and lipoxygenase. Brit. Med. Bull. 1983, 39(3):265-270.
25. Hla T., Nelson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 1992, 89:7384-7388.
26. Jack D.B. One hundred years of aspirin. Lancet 1997, 350:437-439.
27. Jones R. Nonsteroidal anti-inflammatory drug prescribing: past, present, and future. Am. J. Med. 2001, 110(1):S4-S7.
28. Jourdier, S., 2003. A Miracle Drug. <> (accessed 10.11.03). http://www.chemsoc.org/chembytes/ezine/1999/jourdier.htm.
29. Kolbe J. Synthesis of salicylic acid. Prakt. Chem. 1874, 118:107.
30. Kolbe H., Lautemann E. Uber die constitution und basicitat der salicylsaure. Justus Liebigs Ann. Chem. 1860, 115:157-206.
31. Kung, P.C., Peck. K., Lee. Y.-S., Sher. Y.-P., Cheng. Y.-C., 2003. Phytomics: a genomic-based approach to herbal compositions. United States Patent Application No. 20030207270.
32. Leroux H. Discovery of salicine. J. Chim. Med. 1830, 6:340-432.
33. Lev E. Reconstructed materia medica of the medieval and Ottoman al-Sham. J. Ethnopharmacol. 2002, 80:167-179.
34. Lévesque H., Lafont O. L'aspirine à travers les siècles: rappel historique. La Revue de Médecine Interne 2000, 21(1):8s-17s.
35. Loll P.J., Picoti D., Garavito R.M. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat. Struct. Biol. 1995, 2:637-643.
36. MacLagan, T.J., 1876. The treatment of rheumatism by salicin and salicylic acid. Lancet I, 342.
37. Mahdi J.G., Mahdi A.J., Mahdi A.J., Bowen I.D. Historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative Potential. Cell Proliferat. 2006, 39:147-155.
38. Mayer R., Mayer M., Mayer R., Mayer M. Biological salicylate therapy with cortex salicus (Weidenrinde). Pharmazie 1949, 4:77-81.
39. Mindell E. Earl Mindell's Herb Bible 1992, Simon and Schuster, NY.
40. Nunn J.F. Ancient Egyptian Medicine 1996, British Museum Press, London.
41. Pavek, R., Pellerin, C., Reed, J., Swyers, J., 2003. Overview History of Herbal Medicine. <> (accessed 15.11.03). http://www.naturalhealthvillage.com/reports/rpts/rpt2oam/herb.htm.
42. Picot D., Loll P.J., Garavito R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 1994, 367:243-249.
43. Piper J.P., Vane J.R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969, 223:29-35.
44. Piria R. Sur des nouveaux produits extraits de la salicin. C.R. Acad. Sci. Paris 1838, 6:620-624.
45. Rainsford, K.D., 1984. Aspirin and the Salicylates. Butterworth, London, 1984.
46. Raskin I. Role of salicylic acid in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1992, 43:439-463.
47. Riddle J.M. Historical data as an aid in pharmaceutical prospecting and drug safety determination. J. Alt. Complement Med. 1999, 5(2):195-201.
48. Roberts C., Manchester K. The Archaeology of Disease 1995, Cornell University Press, NY.
49. Rosenberg L., Palmer J.R., Zauber A.G., Warshauer M.E., Stolley P.D., Shapiro S. A hypothesis: nonsteroidal antiinflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst. 1999, 83:355-358.
50. Ryals J.A., Neuenschwander U.H., Willits M.G., Molina A., Steiner H.-Y., Hunt M.D. Systemic acquired resistance. Plant Cell 1996, 8:1809-1819.
51. Saggs H.W.F. Civilization Before Greece and Rome 1989, Yale University Press, New Haven.
52. Sneader, W., 2000. The discovery of aspirin: a reappraisal. Brit. Med. J. 321, 1591-1594.
53. Stefano D., Paracelsus V. Light of Europe (parts 1-3). Austral. J. Med. Herbal. 1994, 6(1-3):33-36.
54. Steven D.S. Aspirin and cancer: report on an American Health Foundation Workshop. Prevent. Med. 1995, 24:101-102.
55. Stone E. An account of the success of the bark of the willow in the cure of agues. Philos. Trans. 1763, 53:195.
56. Sumner J. The Natural History of Medicinal Plants 2000, Timber Press, Portland, Oregon.
57. Sutcliffe J., Dunn N. A History of Medicine 1992, Barnes and Noble, NY.
58. Thun M.J., Namboodiri M.M., Heath C.W. Aspirin and reduced risk of fatal colon cancer. New Engl. J. Med. 1991, 325:1593-1596.
59. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol.) 1971, 231:232-235.
60. Vane J.R., Botting R.M. Aspirin and Other Salicylates 1992, Chapman and Hall, London.
61. Vane J.R., Botting R.M. The mechanism of action of aspirin. Thromb. Res. 2003, 110:255-258.
62. Von Gerhardt C. Untersuchungen uber diewasserfreien organischen Saren. Justus Leibig Ann. Chem. 1853, 87:149-178.
63. Yubin L. How to learn Chinese herbs. J. Chin. Med. 2001, 65:18-21.
64. Wells, J.C.D., 2003. Poppy Juice and Willow Bark: Advances in their Use for the 21st Century. The Pain Web for Health Professionals. <> (accessed 24.10.03). http://www.thepainweb.com.
65. Wichtl M., Bisset N.G. Herbal Drugs and Phytopharmaceuticals 1994, Medpharm Scientific Publishers, Stuttgart.
66. Wildermuth M.C., Dewdney J., Wu G., Ausubel F.M. Isochorismate synthase is required to synthesize salicylic acid for plant defence. Nature 2001, 414:562-565.
67. Wilkinson, J., 1997. The Signature of Plants Kindred Spirit. <> (accessed 05.11.03). http://www.herbalgram.org/wholefoodsmarket/herbclip/review.asp.